REPROCELL has submitted an application for manufacturing and marketing approval in Japan for Stemchymal, a regenerative ...
Brii Biosciences has reported topline end-of-treatment data from its ongoing Phase 2b ENRICH and ENHANCE studies evaluat...
Ascletis Pharma has submitted two Investigational New Drug applications to the U.S. FDA for obesity treatment candidates...
Viking Therapeutics has initiated a Phase 1 clinical study of VK3019, an investigational dual amylin and calcitonin rece...
Hong Kong-based Insilico Medicine, a leader in clinical-stage generative AI for drug discovery, has announced a strategi...
NeuroSense Therapeutics has reported positive biomarker findings from its Phase 2 RoAD proof-of-concept study of PrimeC ...
Innovative Molecules has dosed the first patient in its Phase 2a clinical trial evaluating adibelivir for recurrent geni...
Servier has enrolled the first U.S. patient in a Phase Ib/II first-in-human clinical study evaluating an investigational...
CeleCor Therapeutics has completed submission of its New Drug Application to the U.S. FDA for zalunfiban, its investigat...
During BIO 2026 in San Diego, BioSpectrum Asia spoke with Kurt Imhof, Senior Vice President, Policy & Public Affairs...
During the BIO International Convention 2026 (June 22–25) in San Diego, BioSpectrum Asia spoke with Lan Nguyen, Ch...
While most cardiovascular research has traditionally focused on the heart and large blood vessels, a growing body of evi...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
NVIDIA announced NVIDIA BioNeMo Agent Toolkit, which provides domain-specific tools and skills for the agentic life scie...
Haisco Pharmaceutical Group has entered into an exclusive licensing agreement with U.S.-based biotechnology company Nuve...
China-based Abbisko Therapeutics has entered into a strategic research collaboration and licence agreement with US-based...
Lys Therapeutics has raised more than €25 million since its founding in 2021 to advance LYS241, its lead neurovascu...
SystImmune and parent company Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren, als...
AnHorn Medicines has received U.S. FDA Investigational New Drug clearance and Taiwan Center for Drug Evaluation Index Ca...
Insilico Medicine, a Hong Kong-based clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Japan-based startup Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, a colla...
Insilico Medicine has completed first-in-human dosing in the Phase I clinical study of ISM8969, an AI-driven small-molec...
South Korea-based LG AI Research has signed a master agreement with D&D Pharmatech for a joint next-generation oral ...
MindWalk Holdings Corp. is positioning biological data infrastructure as a key bottleneck in AI-enabled drug discovery, ...
Hillhurst Bio has dosed the first subject in its Phase 2a clinical trial evaluating HBI-002 for the treatment of Parkins...
